Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer

Neoadjuvant chemotherapy with docetaxel, oxaliplatin, fluorouracil, and leucovorin (FLOT regimen) has shown promising results in terms of pathological response and survival rate in patients with locally advanced resectable gastric cancer (LAGC). However, tegafur gimeracil oteracil potassium capsule...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nat Commun
Autori principali: Sah, Birendra Kumar, Zhang, Benyan, Zhang, Huan, Li, Jian, Yuan, Fei, Ma, Tao, Shi, Min, Xu, Wei, Zhu, Zhenglun, Liu, Wentao, Yan, Chao, Li, Chen, Liu, Bingya, Yan, Min, Zhu, Zhenggang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705676/
https://ncbi.nlm.nih.gov/pubmed/33257672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19965-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi